Celsion Corporation Gains 28.94%

Fri 22 May 20 at 05:30 PM
Celsion Corporation Gains 28.94%

Celsion Corporation (CLSN:NASDAQ) soared at $3.03, representing a gain of 28.9%. On Thu 21 May 20, CLSN:NASDAQ hit a New 2-Week High of $2.35. The stock appeared on our News Catalysts scanner on Mon 18 May 20 at 01:11 PM in the 'INVESTOR UPDATE' category. From Thu 07 May 20, the stock recorded 70.00% Up Days and 72.73% Green Days

About Celsion Corporation (CLSN:NASDAQ)

Celsion Corp is a fully-integrated oncology drug development company. The Company is engaged in developing a portfolio of cancer treatments, including directed chemotherapies, immunotherapies and RNA- or DNA-based therapies.